Age-related changes in adrenergic regulation of contractility and redox status of glycolytic and oxidative skeletal muscles.

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τίτλος: Age-related changes in adrenergic regulation of contractility and redox status of glycolytic and oxidative skeletal muscles.
Συγγραφείς: Odnoshivkina JG; Laboratory of Biophysics of Synaptic Processes, Federal Research Center, Kazan Institute of Biochemistry and Biophysics, 'Kazan Scientific Center of RAS', 2/31 Lobachevsky Street, Box 30, Kazan, 420111, Russia.; Department of Normal Physiology, Institute of Neuroscience, Kazan State Medical University, 49 Butlerova Street, Kazan, 420012, Russia., Sibgatullina GV; Laboratory of Biophysics of Synaptic Processes, Federal Research Center, Kazan Institute of Biochemistry and Biophysics, 'Kazan Scientific Center of RAS', 2/31 Lobachevsky Street, Box 30, Kazan, 420111, Russia., Dmitrieva SA; Laboratory of Biophysics of Synaptic Processes, Federal Research Center, Kazan Institute of Biochemistry and Biophysics, 'Kazan Scientific Center of RAS', 2/31 Lobachevsky Street, Box 30, Kazan, 420111, Russia., Ponomareva AA; Laboratory of Biophysics of Synaptic Processes, Federal Research Center, Kazan Institute of Biochemistry and Biophysics, 'Kazan Scientific Center of RAS', 2/31 Lobachevsky Street, Box 30, Kazan, 420111, Russia., Khuzakhmetova VF; Laboratory of Biophysics of Synaptic Processes, Federal Research Center, Kazan Institute of Biochemistry and Biophysics, 'Kazan Scientific Center of RAS', 2/31 Lobachevsky Street, Box 30, Kazan, 420111, Russia., Bukharaeva EA; Laboratory of Biophysics of Synaptic Processes, Federal Research Center, Kazan Institute of Biochemistry and Biophysics, 'Kazan Scientific Center of RAS', 2/31 Lobachevsky Street, Box 30, Kazan, 420111, Russia., Petrov AM; Laboratory of Biophysics of Synaptic Processes, Federal Research Center, Kazan Institute of Biochemistry and Biophysics, 'Kazan Scientific Center of RAS', 2/31 Lobachevsky Street, Box 30, Kazan, 420111, Russia. alexey.petrov@kazangmu.ru.; Department of Normal Physiology, Institute of Neuroscience, Kazan State Medical University, 49 Butlerova Street, Kazan, 420012, Russia. alexey.petrov@kazangmu.ru.
Πηγή: GeroScience [Geroscience] 2026 Aug; Vol. 48 (4), pp. 5957-5986. Date of Electronic Publication: 2025 Nov 13.
Τύπος έκδοσης: Journal Article
Γλώσσα: English
Στοιχεία περιοδικού: Publisher: Springer International Publishing Country of Publication: Switzerland NLM ID: 101686284 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2509-2723 (Electronic) Linking ISSN: 25092723 NLM ISO Abbreviation: Geroscience Subsets: MEDLINE
Imprint Name(s): Original Publication: Cham : Springer International Publishing, [2017]-
Ιατρικοί όροι (MeSH): Muscle, Skeletal*/metabolism , Muscle, Skeletal*/drug effects , Muscle, Skeletal*/physiology , Muscle Contraction*/physiology , Muscle Contraction*/drug effects , Aging*/physiology , Oxidative Stress*/physiology , Glycolysis*/physiology, Epinephrine/pharmacology ; Fenoterol/pharmacology ; Animals ; Mice ; Oxidation-Reduction ; Male ; Mice, Inbred C57BL
Περίληψη: Aging is associated with skeletal muscle weakness and oxidative stress. Here, we hypothesized that aging may lead to alterations in adrenoceptor (AR)-dependent regulation of muscle contractility. These changes can aggravate muscle contractile dysfunction and correlate with redox disturbances. Glycolytic extensor digitorum longus (EDL) and oxidative soleus muscles from young adult (3 months), middle-aged (12 months), and old (24 months) mice were used. Contractile responses were elicited by electrical stimulation at different frequencies. During the aging process, inotropic effects of adrenaline in both muscles changed in a similar manner. Adrenaline caused a positive inotropic effect in young adult mice, then its action disappeared at middle age, and, finally, adrenaline decreased the contraction force at old age. Fenoterol, a β-AR agonist, exerted a negative inotropic action in EDL and soleus muscles of young adult and middle-aged mice. This effect of fenoterol is partially preserved in soleus (but not EDL) muscles at advanced age. In both muscles, the positive inotropy of adrenaline was blocked by β2-AR antagonist, whereas the fenoterol-mediated suppression of contraction force was inhibited by β3-AR antagonists. Immunofluorescent labeling revealed both β2- and β3-AR-positive signals at the sarcolemma. Accordingly, the age-related shift of balance from positive to negative inotropic action of adrenaline might be partially dependent on the interplay of β2- and β3-adrenergic signaling in the skeletal muscles. Despite the commonalities in the changes in adrenergic regulation of contractions in both muscles, oxidative stress, decline in antioxidant enzyme activities, and ultrastructural disturbances were much more clearly expressed in aged EDL versus soleus muscles.
(© 2025. The Author(s), under exclusive licence to American Aging Association.)
Competing Interests: Declarations. Ethics approval: The experimental protocols (Protocols #23–1/23–2/2, #23–4/6, 28 February,2023; #23/7 12 May 2023) were approved by the Bioethics Committee of Kazan Federal Scientific Centre and met the requirements of the EU Directive 2010/63/EU as well as European Convention for the Protection of Vertebrate Animals used for Experimental and other Scientific Purposes (Council of Europe No 123, Strasbourg, 1985). Consent for Publication: Not applicable. Conflict of interest: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. All authors consent to publish the article.
References: Exp Gerontol. 2013 May;48(5):492-8. (PMID: 23425621)
Life Sci. 2016 May 1;152:244-8. (PMID: 26596563)
Pflugers Arch. 2024 Mar;476(3):407-421. (PMID: 38253680)
Ann Endocrinol (Paris). 2021 Jun;82(3-4):193-197. (PMID: 32473788)
Ageing Res Rev. 2021 May;67:101305. (PMID: 33610815)
Br J Nutr. 2016 Sep;116(6):979-88. (PMID: 27488121)
Am J Physiol Endocrinol Metab. 2000 Sep;279(3):E663-8. (PMID: 10950836)
Sci Rep. 2021 Apr 28;11(1):9130. (PMID: 33911115)
J Cachexia Sarcopenia Muscle. 2019 Apr;10(2):455-475. (PMID: 30932373)
Eur J Pharmacol. 2015 Oct 15;765:140-53. (PMID: 26297975)
Nat Protoc. 2010 Jan;5(1):51-66. (PMID: 20057381)
Pflugers Arch. 2019 Oct;471(10):1305-1316. (PMID: 31451903)
Exp Gerontol. 2005 Dec;40(12):959-65. (PMID: 16213688)
J Gerontol A Biol Sci Med Sci. 2018 Apr 17;73(5):579-587. (PMID: 29236945)
Ann N Y Acad Sci. 2007 Nov;1119:97-111. (PMID: 18056959)
Sci Rep. 2023 May 16;13(1):7504. (PMID: 37193678)
Am J Physiol. 1990 Apr;258(4 Pt 2):R918-23. (PMID: 2331035)
J Appl Physiol (1985). 1999 Jul;87(1):465-70. (PMID: 10409609)
Nature. 1985 Mar 14-20;314(6007):164-6. (PMID: 3974720)
J Appl Physiol (1985). 2005 Jul;99(1):95-102. (PMID: 15746299)
J Lab Clin Med. 1967 Jul;70(1):158-69. (PMID: 6066618)
J Proteome Res. 2013 Oct 4;12(10):4532-46. (PMID: 24001182)
J Exp Biol. 1985 Mar;115:125-36. (PMID: 4031760)
J Vet Med Sci. 2008 Jan;70(1):115-8. (PMID: 18250584)
Sci Rep. 2022 Oct 14;12(1):17289. (PMID: 36241693)
Pflugers Arch. 1987 Mar;408(3):224-30. (PMID: 3033599)
J Appl Physiol (1985). 2006 Sep;101(3):898-905. (PMID: 16709649)
Mech Ageing Dev. 2007 Mar;128(3):267-75. (PMID: 17224177)
Sci Rep. 2016 Nov 22;5:37504. (PMID: 27874066)
Mech Ageing Dev. 2006 Nov;127(11):830-9. (PMID: 16996110)
J Appl Physiol (1985). 2008 Jul;105(1):165-72. (PMID: 18436698)
Mech Ageing Dev. 2001 Jul 31;122(10):1019-32. (PMID: 11389921)
Free Radic Res. 2000 Sep;33(3):287-93. (PMID: 10993482)
Acta Neuropathol Commun. 2014 Jan 02;2:2. (PMID: 24383498)
Geriatr Gerontol Int. 2010 Jul;10 Suppl 1:S127-36. (PMID: 20590828)
Br J Pharmacol. 1993 Nov;110(3):1133-41. (PMID: 8298802)
Acta Physiol Scand. 1978 Nov;104(3):249-61. (PMID: 716979)
Neurochem Res. 2025 May 12;50(3):162. (PMID: 40353941)
Cell Death Dis. 2024 Jun 28;15(6):459. (PMID: 38942747)
J Mol Histol. 2004 Jun;35(5):489-99. (PMID: 15571326)
Anal Biochem. 1979 Jun;95(2):351-8. (PMID: 36810)
Arch Gerontol Geriatr. 1997 Sep-Oct;25(2):175-86. (PMID: 18653104)
Mol Neurobiol. 2024 Sep;61(9):6805-6821. (PMID: 38353924)
Int J Obes Relat Metab Disord. 1999 Oct;23(10):1057-65. (PMID: 10557026)
Histochem Cell Biol. 2025 Apr 03;163(1):42. (PMID: 40178695)
Free Radic Biol Med. 2025 Feb 01;227:446-458. (PMID: 39613046)
Pflugers Arch. 2013 Apr;465(4):509-16. (PMID: 23334408)
Proc Natl Acad Sci U S A. 2016 Jan 19;113(3):746-50. (PMID: 26733679)
J Physiol Sci. 2009 Sep;59(5):383-90. (PMID: 19585216)
Redox Biol. 2022 Nov;57:102518. (PMID: 36283174)
Eur J Pharmacol. 2012 Sep 5;690(1-3):202-6. (PMID: 22760074)
Aging Cell. 2011 Dec;10(6):1047-55. (PMID: 21933339)
Physiol Rev. 2008 Apr;88(2):729-67. (PMID: 18391178)
Int J Mol Sci. 2024 Aug 17;25(16):. (PMID: 39201644)
Anal Biochem. 1989 Nov 15;183(1):195-6. (PMID: 2619044)
Elife. 2023 Mar 23;12:. (PMID: 36951533)
Front Physiol. 2024 Jan 22;15:1268380. (PMID: 38318197)
J Physiol. 2004 Feb 15;555(Pt 1):175-88. (PMID: 14617677)
BMC Geriatr. 2013 Oct 07;13:104. (PMID: 24093947)
Free Radic Biol Med. 2006 Jun 1;40(11):1993-2004. (PMID: 16716900)
Biogerontology. 2002;3(1-2):45-9. (PMID: 12014841)
J Gerontol A Biol Sci Med Sci. 2007 Aug;62(8):813-23. (PMID: 17702871)
Neurochem Res. 2025 Sep 11;50(5):298. (PMID: 40932671)
Mech Ageing Dev. 2000 Jul 10;116(1):33-45. (PMID: 10936506)
J Cachexia Sarcopenia Muscle. 2021 Dec;12(6):1908-1924. (PMID: 34546662)
Sci Rep. 2020 Aug 18;10(1):13968. (PMID: 32811851)
J Clin Invest. 2020 May 1;130(5):2319-2331. (PMID: 31961829)
J Physiol. 2000 Nov 1;528(Pt 3):407-17. (PMID: 11060120)
J Biol Chem. 2003 Aug 15;278(33):31426-33. (PMID: 12775726)
Neuroscience. 2019 Feb 10;399:135-145. (PMID: 30593920)
Front Physiol. 2022 Oct 04;13:937132. (PMID: 36267576)
Age (Dordr). 2015 Jun;37(3):9773. (PMID: 25893911)
Stem Cell Res Ther. 2021 Sep 16;12(1):505. (PMID: 34530910)
Physiol Rep. 2018 May;6(9):e13690. (PMID: 29718592)
Front Cell Dev Biol. 2022 Aug 30;10:964130. (PMID: 36111339)
Acta Neuropathol. 1993;86(5):521-4. (PMID: 8310803)
J Gerontol A Biol Sci Med Sci. 1995 Nov;50 Spec No:11-6. (PMID: 7493202)
Ageing Res Rev. 2021 Jan;65:101200. (PMID: 33130247)
Br J Pharmacol. 1996 Jan;117(1):210-6. (PMID: 8825365)
Ann Neurol. 2018 Feb;83(2):269-282. (PMID: 29328520)
Arch Toxicol. 2025 Jul;99(7):2877-2901. (PMID: 40234311)
J Physiol. 2015 Nov 1;593(21):4713-27. (PMID: 26400207)
J Neurophysiol. 2000 Apr;83(4):2002-11. (PMID: 10758110)
J Gerontol A Biol Sci Med Sci. 2008 Aug;63(8):829-34. (PMID: 18772470)
J Physiol. 1988 Oct;404:71-82. (PMID: 3253447)
J Clin Invest. 1996 Jun 15;97(12):2898-904. (PMID: 8675704)
Br J Pharmacol. 2010 Jul;160(5):1048-61. (PMID: 20590599)
Int J Mol Med. 2021 Aug;48(2):. (PMID: 34184088)
Pharmacol Res. 2015 Sep;99:86-100. (PMID: 26048279)
Cell Signal. 2021 Apr;80:109905. (PMID: 33385503)
Free Radic Biol Med. 1998 Dec;25(9):1089-97. (PMID: 9870563)
Methods Enzymol. 1984;105:121-6. (PMID: 6727660)
Free Radic Biol Med. 1999 Sep;27(5-6):617-22. (PMID: 10490283)
Naunyn Schmiedebergs Arch Pharmacol. 1977 Dec;301(2):109-13. (PMID: 23500)
Free Radic Biol Med. 1999 Feb;26(3-4):303-8. (PMID: 9895220)
Endocrinol Metab (Seoul). 2022 Jun;37(3):552-557. (PMID: 35798554)
Eur J Pharmacol. 2000 Oct 6;406(1):33-40. (PMID: 11011029)
J Physiol. 1981 Jul;316:545-54. (PMID: 7320881)
Grant Information: 23-15-00124 Russian Science Foundation
Contributed Indexing: Keywords: Adrenaline; Adrenoceptor; Aging; Contraction; Oxidative stress; Sarcopenia; Skeletal muscle
Substance Nomenclature: YKH834O4BH (Epinephrine)
22M9P70OQ9 (Fenoterol)
Entry Date(s): Date Created: 20251113 Date Completed: 20260914 Latest Revision: 20260917
Update Code: 20260917
PubMed Central ID: PMC13575024
DOI: 10.1007/s11357-025-02005-w
PMID: 41231352
Βάση Δεδομένων: MEDLINE